[HTML][HTML] Lower Urinary Tract Symptoms in Depression: A Review

DJ Anderson, A Aucoin, CR Toups… - Health Psychology …, 2023 - ncbi.nlm.nih.gov
Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

[HTML][HTML] Buprenorphine and its formulations: a comprehensive review

S Poliwoda, N Noor, JS Jenkins, CW Stark… - Health Psychology …, 2022 - ncbi.nlm.nih.gov
Buprenorphine, a novel long-acting analgesic, was developed with the intention of two
purposes: analgesia and opioid use disorder. Regarding its pharmacodynamics, it is a …

Low-dose initiation of buprenorphine: a narrative review

AN Edinoff, OH Fahmy, NJ Spillers, AR Zaheri… - Current Pain and …, 2023 - Springer
Abstract Purpose of Review Opioid use disorder (OUD) is a chronic disorder in which a
person loses control over the use of opioids, develops a compulsive behavior, and defends …

Patients on buprenorphine formulations undergoing surgery

K Champagne, P Date, JP Forero, J Arany… - Current pain and …, 2022 - Springer
Abstract Purpose of Review To review the pharmacology of buprenorphine, the evolution of
buprenorphine dosing recommendations, and the current literature regarding its …

Opioid effects and classification

SL Cruz, MI Paz-Ramos… - … , Abuse, and Addiction, 2022 - Springer
This chapter describes the main groups of opioid receptor ligands based on their origin,
chemical structure, and pharmacological actions. The first section describes natural …

Qualitative exploration of the psychological dimensions of telehealth shared medical appointments (SMAs) for buprenorphine prescribing

B Greenberg, AC Oft, L Lucitt, NA Haug… - Journal of Addictive …, 2024 - Taylor & Francis
Abstract Background: Shared medical appointments (SMAs) for buprenorphine prescribing
are clinical encounters in which multiple patients with opioid problems receive treatment …

[PDF][PDF] Buprenorphine not a silver bullet but an opioid of choice for chronic pain

MP Davis, J Fudin - Journal of Opioid Management, 2021 - wmpllc.org
Mellar P. Davis, MD, FCCP, FAAHPM; Jeffrey Fudin, PharmD, FACCP, FASHP, FFSMB
buprenorphine of 10-12 nanograms/ml (ng/ml), norbuprenorphine 1 ng/ml, buprenorphine-3 …

What's the buzz about buprenorphine? A pharmacologic overview

DJ Moore - Nursing made Incredibly Easy, 2022 - journals.lww.com
Buprenorphine is a drug you may not have heard about, but it's very likely you'll encounter a
patient who uses it. Buprenorphine is a synthetic opioid medication approved to treat opioid …

Naše první zkušenosti s novou formou transdermálního buprenorfinu.

J Procházka - Remedia, 2024 - search.ebscohost.com
Buprenorfin v transdermální formě se dlouhodobě používá v léčbě chronické středně silné
až silné bolesti nádorového i nenádorového původu. Nyní je k dispozici v nové formě s …

[PDF][PDF] Buprenorphine and Pain

C Kuwata - cmeinfo.com
488-22 Kuwata Page 1 Buprenorphine and Pain Caitlyn Kuwata MD Assistant Professor
Department of Geriatrics and Palliative Medicine Disclosure No conflicts of interest or financial …